Fundraising Fox
Epilepsy GTx
9 employees on LinkedIn · 5 known investors
Find your way into Epilepsy GTx
EpilepsyGTx is a preclinical-stage biotech developing gene therapies for focal refractory epilepsy (FRE), with the aim of making patients seizure free.
Investors · 5
AlbionVClisted by AlbionVCLondon
How we know: AlbionVC's portfolio page · a partner's Signal profile · Not right? Tell us
XGEN Venturelisted by XGEN VentureMilan
How we know: XGEN Venture's portfolio page · funding news · Not right? Tell us
British Business BankreportedSheffield
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$33M disclosed across 1 of 2 rounds · 2024–2025
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Epilepsy GTx do?
- EpilepsyGTx is a preclinical-stage biotech developing gene therapies for focal refractory epilepsy (FRE), with the aim of making patients seizure free.
- Who are Epilepsy GTx's investors?
- Epilepsy GTx's investors include AlbionVC, Moonstone Venture Capital, UCL Technology Fund, XGEN Venture, British Business Bank.
- How much funding has Epilepsy GTx raised?
- Epilepsy GTx has disclosed $33M raised across 1 of its 2 known rounds.